reported another patient with multiple primary lung adenocarcinoma who simultaneously had CD74-NRG1 fusion, EGFR, and human epidermal growth factor receptor 2 (ERBB2) mutations (99). This evidence concerns the gene ERBB2 and lung adenocarcinoma.